Most Voters Want Immunity for Vaccine Companies Removed: Poll + More
Source: Children’s Health Defense
Most Voters Want Immunity for Vaccine Companies Removed: Poll
A majority of voters say immunity for pharmaceutical firms should be removed in cases where the companies’ vaccines cause injuries, according to a new poll. Sixty percent of voters responding to the poll agreed that vaccine manufacturers should be stripped of immunity in such cases, including 33 percent who strongly backed withdrawing the immunity. Majorities across all age groups, genders, and races also supported the immunity abolishment.
Just 27.5 percent of respondents did not think the immunity should end, while 12.6 percent of respondents said they were not sure. The survey was carried out by Big Data Poll for the 1776 Law Center. “Few single issues enjoy more support across every group of Americans than ending all immunity for Big Pharma,” Robert Barnes, the civil rights and criminal defense attorney who heads the law center, said in a statement. “That includes their vaccines when those vaccines cause injury.”
“As we have seen with food and financial freedoms, the proposals are supported most vigorously among the voters the administration badly needs to win back over,” Big Data Poll Director Rich Baris added. “That includes voters below 65 years old and minorities that previously voted for the president in 2024.”
Dentists Still Write Millions of Prescriptions a Year for an Antibiotic With Life-Threatening Risks
Dentists wrote more than 2.3 million prescriptions last year for an antibiotic called clindamycin, whose label has carried a black box warning for more than four decades, due to its high rate of life-threatening complications. One of those prescriptions was given to Dolores Hernandez Owens.
Owens, 92, lived with her husband of 45 years in a small yellow house with a white fence in southern California. She relished feeding the people she loved, preparing both the Mexican dishes on which she was raised, and the soul food her husband savored. She tended the flower garden and fruit trees in her yard, gathering armfuls of lemons, grapefruits, and figs as presents for her family.
Owens was also a woman of faith. Her favorite Gospel songs could inspire her to dance with joy, rocking from side to side, gently waving her arms and smiling. One year ago, her dentist told Owens that she needed a tooth pulled. Owens took the news in stride, joking that she might have to chew with her front teeth from now on, said her son, Robert Flournoy. Her dentist prescribed clindamycin, the second-most commonly used drug in dentistry. That’s when Owens’ life changed.
Free Gardasil Vaccine for Teenage Girls: Centre Plans Major HPV Prevention Push
In a major move towards preventive healthcare for adolescents, the government is soon set to launch a countrywide HPV vaccination campaign for girls aged 14 years and above, as announced by government officials. The move is expected to make the Gardasil vaccine available for free, with the aim of lowering the long-term prevalence of cervical cancer and other HPV-related diseases in India.
Health experts have for long advocated for early vaccination as the best means of fighting Human Papillomavirus (HPV), which is responsible for a high percentage of cervical cancer. The proposed campaign will be conducted through schools and health facilities, with awareness programs to be conducted to fight resistance to vaccination.
As reported by PTI, “Strong global and Indian scientific evidence confirms that a single dose provides robust and durable protection when administered to girls in the recommended age group,” an official source said. “Vaccination under the national programme will be voluntary and free of cost, ensuring equitable access across socio-economic groups,” the source added.
Universal Vaccine to Treat Colds, Flu and COVID Developed, and a New Study Suggests It Just Might Work
Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium — in effect, showing it a wanted poster for a single suspect. But what if one vaccine could protect against dozens of different infections at once? Researchers have now developed a potential candidate for such a vaccine, and a study in mice, published in the journal Science, offers promising results.
Most vaccines work by introducing the immune system to a specific pathogen — a weakened version of it, or a key protein from its surface — so that the body can recognize and fight it if it is encountered later. This vaccine takes a fundamentally different approach. Rather than targeting any one bug, it contains molecules that mimic the signals the body naturally produces when it is under attack from a virus or bacterium.
The effect is to put certain immune cells into a prolonged state of high alert, ready to respond rapidly to a wide range of threats, rather than being trained to spot just one.
However, the consequences of dialing up the immune system beyond its normal state won’t be known until human trials are conducted.
BioNTech’s Personalized mRNA Breast Cancer Vaccine Shows Durable Immune Signals in Early Trial
A Phase I study published in Nature reports encouraging early data for a personalized mRNA neoantigen vaccine in triple-negative breast cancer (TNBC), one of the most aggressive breast cancer subtypes. The exploratory trial, led by Marcus Schmidt at University Medical Centre Mainz in collaboration with BioNTech SE, treated 14 early-stage TNBC patients following surgery and (neo)adjuvant therapy.
Each individualized vaccine encoded up to 20 tumor-specific neoantigens, delivered intravenously via lipid nanoparticles to activate dendritic cells. All 14 patients developed vaccine-induced T-cell responses targeting multiple neoantigens. CD8+ T cells reached levels typically associated with adoptive cell therapies and remained functionally active for years without boosters.
Proposal Would Loosen Rabies Vaccine Requirements for Certain Pets — for a Fee
New Hampshire Bulletin reported:
The New Hampshire House of Representatives is considering a bill that would exempt some pets from booster shots intended to protect against rabies, but state veterinarians said the proposal was not founded on solid data. Rep. Keith Ammon, a New Boston Republican, is the prime sponsor of House Bill 1488, which would allow pet owners to bypass a state-required rabies booster by presenting the results of a test affirming their pet has some level of immunity to the deadly disease in their system from a previous vaccine.
The proposal, Ammon said, was requested by a constituent seeking a way to bypass the state’s requirement because of concerns about secondary effects of the vaccine and a belief that the current schedule is excessive. But a decrease in rabies vaccination rates could be deadly for both people and animals, and the alternative testing called for in the proposal does not provide sufficient evidence that an animal is immune to rabies, said New Hampshire State Veterinarian Mark Prescott.
New Hampshire law currently requires dogs, cats, and ferrets older than 3 months of age receive an initial rabies vaccine followed by a series of booster shots on a schedule determined by a national veterinary organization. HB 1488 leaves in place the requirement for an initial vaccine and subsequent booster, but would allow pet owners to bypass further boosters if they continue to present valid test results.
Some pet owners at a Feb. 17 public hearing spoke in favor of the bill, saying the current protocol required to attain a medical exemption for their pet was too difficult.
Recent Top Stories
Sorry, we couldn't find any posts. Please try a different search.
